Background To curb the emergence of antibiotic-resistant Mycobacterium leprae strains, the WHO recommends monitoring of antimicrobial resistance (AMR). In Madagascar, molecular surveillance of resistance to anti- M. leprae drugs remains limited geographically and in terms of quantitative data. A clinical trial on leprosy prophylaxis (PEOPLE) conducted in the district of Miandrivazo provided an opportunity to explore the feasibility of an integrated approach for improving leprosy surveillance and resistance monitoring in Madagascar. This study aimed to i) determine the genetic diversity of the identified M. leprae strains, (ii) detect mutations associated with AMR, (iii) evaluate and compare the acceptance rate of low-invasive sampling methods with that of skin biopsies, and (iv) assess seropositivity for anti- M. leprae PGL-I IgM. Methods Patients were identified through door-to-door screening and skin biopsies (SB), fingerstick blood (FSB) and nasal swabs (NS) were collected. SB were analyzed by RLEP qPCR for detection of M. leprae DNA, resistance testing using LiPA (Line Probe Assay), and resistance analysis and SNP and/or VNTR genotyping using Sanger sequencing and Deeplex Myc-Lep. NS samples were used to assess M.leprae carriage by RLEP qPCR, and FSB samples to detect past and/or present infection by measuring anti- M. leprae PGL-I IgM levels. Results 80 leprosy patients were identified, including 41 multibacillary and 39 paucibacillary. Out of these, 57 accepted NS, 47 FSB, and 33 SB. High levels of anti-PGL-I IgM were detected in 6/47 FSB samples. RLEP qPCR was positive in 4/57 NS samples and 28/33 SB samples. Among SB positive, 12 yielded interpretable results when combining data from LiPA, Deeplex Myc-Lep, and Sanger sequencing. No drug resistance-conferring mutations were detected among the analyzable samples. All strains belonged to the 1D-Malagasy genotype, and VNTR analysis for 7 samples with results available across 9 loci showed 7 unique types, with loci GAA21, GTA9, and AC8a were the most informative for strain differentiation. Conclusion Although the results of this pilot study are based on a limited number of analyzable samples, mostly collected from patients already receiving MDT, these findings support the feasibility of field-based molecular surveillance and provide a foundation for expanding AMR monitoring in Madagascar.
Maharavo, Luca, Ramboarina, Stéphanie, Braet, Sofie Marijke et al. Assessing improved surveillance of leprosy drug resistance in Madagascar: a pilot study in the Miandrivazo district. // Mycobacteria. – 2026. – DOI: 10.1186/s44350-026-00022-z. – URL: https://www.biomedcentral.com/openurl?doi=10.1186/s44350-026-00022-z
Maharavo, Luca, Ramboarina, Stéphanie, Braet, Sofie Marijke, Corstjens, Paul, Jong, Danielle, Randrianantoandro, Andriamira, Andrianiriana, Lovasoa Mbolamanana Joseph, Andrianarivelo, Mala Rakoto, Berland, Jean Luc, Cambau, Emmanuelle, Supply, Philip, Jouet, Agathe, Hasker, Epco, Jong, Bouke Catherine, Cauchoix, Bertrand, Rasamoelina, Tahinamandranto, Samison, Luc Hervé, Geluk, & Annemieke (2026). Assessing improved surveillance of leprosy drug resistance in Madagascar: a pilot study in the Miandrivazo district. Mycobacteria. https://doi.org/10.1186/s44350-026-00022-z
Maharavo, et al. “Assessing improved surveillance of leprosy drug resistance in Madagascar: a pilot study in the Miandrivazo district.” Mycobacteria, 2026. doi:10.1186/s44350-026-00022-z.
@article{Maharavo2026,
title = {Assessing improved surveillance of leprosy drug resistance in Madagascar: a pilot study in the Miandrivazo district},
author = {Maharavo and Luca and Ramboarina and Stéphanie and Braet and Marijke, Sofie and Corstjens and Paul and Jong and Danielle and Randrianantoandro and Andriamira and Andrianiriana and Joseph, Lovasoa Mbolamanana and Andrianarivelo and Rakoto, Mala and Berland and Luc, Jean and Cambau and Emmanuelle and Supply and Philip and Jouet and Agathe and Hasker and Epco and Jong and Catherine, Bouke and Cauchoix and Bertrand and Rasamoelina and Tahinamandranto and Samison and Hervé, Luc and Geluk and Annemieke},
journal = {Mycobacteria},
year = {2026},
doi = {10.1186/s44350-026-00022-z},
url = {https://www.biomedcentral.com/openurl?doi=10.1186/s44350-026-00022-z}
}
Background Diesel exhaust particles (DEP) are a major component of combustion-derived PM_2.5 and contain complex mixtures of organic and inorganic contaminants associated with elemental carbon (black carbon). Diesel particulate matter...
Background Triptolide (TP), a bioactive diterpenoid derived from Tripterygium wilfordii Hook F., exhibits potent anti-inflammatory and immunosuppressive activities but has a narrow therapeutic window and documented toxicities in...
Background Residents living near smelters and abandoned metal mines may experience chronic heavy metal exposure through multiple environmental pathways. Proteomic profiling provides a promising approach for identifying early biological...
Backgrounds Micro- and nanoplastics are associated with metabolic toxicity, but their effects on hepatic cholesterol homeostasis and potential mitigating interventions remain insufficiently characterized. Objectives To characterize...
Background Per- and polyfluoroalkyl substances (PFAS) are persistent environmental contaminants that accumulate in human tissues and may cause prolonged cellular and organ damage. Ferroptosis, an iron-dependent form of regulated cell...